← Leaderboards
Alexei Degterev
Harvard University (Medical School)
$8,573,527
Attributed
$14,565,469
Total exposure
12
Grants
9
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $2.1M · FY2005–25$2.5M$1.9M$1.3M$625K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$14,565,469 · 12
By mechanism
R01$10,806,660 · 4
R21$2,515,814 · 6
R56$648,995 · 1
K01$594,000 · 1
Top collaborators
- Gregory D Cuny9 shared
- Siddharth Balachandran6 shared
- Yongjie Yang6 shared
- Rebecca Batorsky2 shared
- Scott A. Gerber2 shared
- Albert K Tai2 shared
Most similar at Harvard University (Medical School)
Same institution · by research overlap
- Junying Yuan$25,408,972
Others in their field
Top investigators on “In Vivo”
- David Heimbrook · Leidos Biomedical Research, Inc.$371,850,582
- Leonard Freedman · Leidos Biomedical Research, Inc.$304,459,298
- Dennis R. Burton · Scripps Research Institute$212,708,174
- Mark S Klempner · Tufts Medical Center$128,021,180
- Florian Krammer · Icahn School Of Medicine At Mount Sinai$104,723,856
- David M. Margolis · University Of Texas Sw Med Ctr/Dallas$98,374,200
Research focus
In VivoCellsIn VitroNecrosisCell DeathPathway InteractionsApoptosisPhosphotransferasesComplexSmall MoleculeAlzheimer&AposPathologicBaseAcuteCessation Of LifeInjuryMolecularCell TypeMediator Of Activation ProteinMediatingSignal TransductionInhibitor/AntagonistPlayPrograms
Grant awards (34)
CNS Exosomes-Mediated Adaptive Immunity in Alzheimer's Disease (AD)$816,608
R01 · FY2025 · AG
Understanding heterogeneity of necroptotic cell death and mechanism(s) of necroptosis escape$450,764
R21 · FY2025 · AI · contact PI
Analysis of the heterogeneity of cell death responses in the influenza virus-infected cells$239,120
R21 · FY2025 · AI · contact PI
CNS Exosomes-Mediated Adaptive Immunity in Alzheimer's Disease (AD)$896,099
R01 · FY2024 · AG
CNS Exosomes-Mediated Adaptive Immunity in Alzheimer's Disease (AD)$898,610
R01 · FY2023 · AG
Targeting RIPK3 in Flu-Associated Lung Injury$702,005
R01 · FY2023 · AI
Analyzing Oligodendrocytes-Derived Exosomes in Mouse Models of Multiple Sclerosis$247,500
R21 · FY2023 · NS · contact PI
CNS Exosomes-Mediated Adaptive Immunity in Alzheimer's Disease (AD)$933,576
R01 · FY2022 · AG
Targeting RIPK3 in Flu-Associated Lung Injury$731,691
R01 · FY2022 · AI
Analyzing Oligodendrocytes-Derived Exosomes in Mouse Models of Multiple Sclerosis$206,250
R21 · FY2022 · NS · contact PI
Degrader probes for necroptosis pathway$197,400
R21 · FY2022 · AI
Targeting RIPK3 in Flu-Associated Lung Injury$789,265
R01 · FY2021 · AI
Degrader probes for necroptosis pathway$250,500
R21 · FY2021 · AI
Targeting RIPK3 in Flu-Associated Lung Injury$678,878
R01 · FY2020 · AI
Targeting RIPK3 in Flu-Associated Lung Injury$719,078
R01 · FY2019 · AI
Targeting RIPK1 and RIPK2 kinases in mouse Experimental Autoimmune Encephalomyelitis$457,880
R21 · FY2019 · NS · contact PI
Targeting RIPK3 in Age-Related Inflammation and Injury$648,995
R56 · FY2018 · AG · contact PI
Dissection of the new pro-inflammatory components of the necrosome complex$245,550
R21 · FY2018 · AI · contact PI
Dissection of the new pro-inflammatory components of the necrosome complex$220,850
R21 · FY2017 · AI · contact PI
Mechanistic analysis of necrostatins: specific inhibitors of programmed necrosis$371,857
R01 · FY2012 · GM · contact PI
Molecular and functional analysis of necroptosis initiation complex$368,018
R01 · FY2012 · GM · contact PI
Mechanistic analysis of necrostatins: specific inhibitors of programmed necrosis$412,647
R01 · FY2011 · GM · contact PI
Molecular and functional analysis of necroptosis initiation complex$368,016
R01 · FY2011 · GM · contact PI
Mechanistic analysis of necrostatins: specific inhibitors of programmed necrosis$436,793
R01 · FY2010 · GM · contact PI
Molecular and functional analysis of necroptosis initiation complex$371,576
R01 · FY2010 · GM · contact PI
Mechanistic analysis of necrostatins: specific inhibitors of programmed necrosis$473,960
R01 · FY2009 · GM · contact PI
Molecular and functional analysis of necroptosis initiation complex$375,398
R01 · FY2009 · GM · contact PI
Mechanistic analysis of necrostatins: specific inhibitors of programmed necrosis$71,620
R01 · FY2009 · GM · contact PI
Molecular and functional analysis of necroptosis initiation complex$390,965
R01 · FY2008 · GM · contact PI
Caspase-independent cell death and neurodegeneration$118,800
K01 · FY2006 · AG · contact PI
Caspase-independent cell death and neurodegeneration$118,800
K01 · FY2005 · AG
Caspase-independent cell death and neurodegeneration$118,800
K01 · FY2004 · AG
Caspase-independent cell death and neurodegeneration$118,800
K01 · FY2003 · AG
Caspase-independent cell death and neurodegeneration$118,800
K01 · FY2002 · AG